Journal Article
M. Koponen, Taipale, H., Lavikainen, P., Tanskanen, A., Tiihonen, J., Tolppanen, A. - M., Ahonen, R., and Hartikainen, S.,
“Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.”,
J Alzheimers Dis, vol. 56, no. 1, pp. 107-118, 2017.
M. Koponen, Taipale, H., Lavikainen, P., Tanskanen, A., Tiihonen, J., Tolppanen, A. - M., Ahonen, R., and Hartikainen, S.,
“Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.”,
J Alzheimers Dis, vol. 56, no. 1, pp. 107-118, 2017.
M. Koponen, Taipale, H., Lavikainen, P., Tanskanen, A., Tiihonen, J., Tolppanen, A. - M., Ahonen, R., and Hartikainen, S.,
“Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.”,
J Alzheimers Dis, vol. 56, no. 1, pp. 107-118, 2017.
M. Koponen, Taipale, H., Lavikainen, P., Tanskanen, A., Tiihonen, J., Tolppanen, A. - M., Ahonen, R., and Hartikainen, S.,
“Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.”,
J Alzheimers Dis, vol. 56, no. 1, pp. 107-118, 2017.
D. - D. Zhang, Ou, Y. - N., Fu, Y., Wang, Z. - B., Huang, L. - Y., Tan, L., and Yu, J. - T.,
“Risk of Dementia in Cancer Survivors: A Meta-Analysis of Population-Based Cohort Studies.”,
J Alzheimers Dis, vol. 89, no. 1, pp. 367-380, 2022.
F. E. Taragano, Allegri, R. F., Heisecke, S. L., Martelli, M. I., Feldman, M. L., Sánchez, V., García, V. A., Tufro, G., Castro, D. M., Leguizamón, P. Perez, Guelar, V., Ruotolo, E., Zegarra, C., and Dillon, C.,
“Risk of Conversion to Dementia in a Mild Behavioral Impairment Group Compared to a Psychiatric Group and to a Mild Cognitive Impairment Group.”,
J Alzheimers Dis, vol. 62, no. 1, pp. 227-238, 2018.
F. E. Taragano, Allegri, R. F., Heisecke, S. L., Martelli, M. I., Feldman, M. L., Sánchez, V., García, V. A., Tufro, G., Castro, D. M., Leguizamón, P. Perez, Guelar, V., Ruotolo, E., Zegarra, C., and Dillon, C.,
“Risk of Conversion to Dementia in a Mild Behavioral Impairment Group Compared to a Psychiatric Group and to a Mild Cognitive Impairment Group.”,
J Alzheimers Dis, vol. 62, no. 1, pp. 227-238, 2018.
A. Elias, Cummins, T., Tyrrell, R., Lamb, F., Doré, V., Williams, R., Rosenfeld, J. V., Hopwood, M., Villemagne, V. L., and Rowe, C. C.,
“Risk of Alzheimer's Disease in Obstructive Sleep Apnea Syndrome: Amyloid-β and Tau Imaging.”,
J Alzheimers Dis, vol. 66, no. 2, pp. 733-741, 2018.
Y. - N. Song, Wang, P., Xu, W., Li, J. - Q., Cao, X. - P., Yu, J. - T., and Tan, L.,
“Risk Factors of Rapid Cognitive Decline in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.”,
J Alzheimers Dis, vol. 66, no. 2, pp. 497-515, 2018.
B. Gyanwali, Shaik, M. Amin, Tan, B. Yeow, Venketasubramanian, N., Chen, C., and Hilal, S.,
“Risk Factors for and Clinical Relevance of Incident and Progression of Cerebral Small Vessel Disease Markers in an Asian Memory Clinic Population.”,
J Alzheimers Dis, vol. 67, no. 4, pp. 1209-1219, 2019.
L. C. Silbert, Lahna, D., Promjunyakul, N. - O., Boespflug, E., Ohya, Y., Higashiuesato, Y., Nishihira, J., Katsumata, Y., Tokashiki, T., and Dodge, H. H.,
“Risk Factors Associated with Cortical Thickness and White Matter Hyperintensities in Dementia Free Okinawan Elderly.”,
J Alzheimers Dis, vol. 63, no. 1, pp. 365-372, 2018.
H. Ulugut Erkoyun, van der Lee, S. J., Nijmeijer, B., van Spaendonk, R., Nelissen, A., Scarioni, M., Dijkstra, A., Samancı, B., Gürvit, H., Yıldırım, Z., Tepgeç, F., Bilgic, B., Barkhof, F., Rozemuller, A., van der Flier, W. M., Scheltens, P., Cohn-Hokke, P., and Pijnenburg, Y.,
“The Right Temporal Variant of Frontotemporal Dementia Is Not Genetically Sporadic: A Case Series.”,
J Alzheimers Dis, vol. 79, no. 3, pp. 1195-1201, 2021.
E. Andreadou, Pantazaki, A. A., Daniilidou, M., and Tsolaki, M.,
“Rhamnolipids, Microbial Virulence Factors, in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 59, no. 1, pp. 209-222, 2017.
H. Hampel, Toschi, N., Babiloni, C., Baldacci, F., Black, K. L., Bokde, A. L. W., Bun, R. S., Cacciola, F., Cavedo, E., Chiesa, P. A., Colliot, O., Coman, C. - M., Dubois, B., Duggento, A., Durrleman, S., Ferretti, M. - T., George, N., Genthon, R., Habert, M. - O., Herholz, K., Koronyo, Y., Koronyo-Hamaoui, M., Lamari, F., Langevin, T., Lehéricy, S., Lorenceau, J., Neri, C., Nisticò, R., Nyasse-Messene, F., Ritchie, C., Rossi, S., Santarnecchi, E., Sporns, O., Verdooner, S. R., Vergallo, A., Villain, N., Younesi, E., Garaci, F., and Lista, S.,
“Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.”,
J Alzheimers Dis, vol. 64, no. s1, pp. S47-S105, 2018.
I. Pelcher, Puzo, C., Tripodis, Y., Aparicio, H. J., Steinberg, E. G., Phelps, A., Martin, B., Palmisano, J. N., Vassey, E., Lindbergh, C., McKee, A. C., Stein, T. D., Killiany, R. J., Au, R., Kowall, N. W., Stern, R. A., Mez, J., and Alosco, M. L.,
“Revised Framingham Stroke Risk Profile: Association with Cognitive Status and MRI-Derived Volumetric Measures.”,
J Alzheimers Dis, vol. 78, no. 4, pp. 1393-1408, 2020.
E. Niemantsverdriet, Ribbens, A., Bastin, C., Benoit, F., Bergmans, B., Bier, J. - C., Bladt, R., Claes, L., De Deyn, P. Paul, Deryck, O., Hanseeuw, B., Ivanoiu, A., Lemper, J. - C., Mormont, E., Picard, G., Salmon, E., Segers, K., Sieben, A., Smeets, D., Struyfs, H., Thiery, E., Tournoy, J., Triau, E., Vanbinst, A. - M., Versijpt, J., Bjerke, M., and Engelborghs, S.,
“A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER).”,
J Alzheimers Dis, vol. 63, no. 4, pp. 1509-1522, 2018.
E. Niemantsverdriet, Ribbens, A., Bastin, C., Benoit, F., Bergmans, B., Bier, J. - C., Bladt, R., Claes, L., De Deyn, P. Paul, Deryck, O., Hanseeuw, B., Ivanoiu, A., Lemper, J. - C., Mormont, E., Picard, G., Salmon, E., Segers, K., Sieben, A., Smeets, D., Struyfs, H., Thiery, E., Tournoy, J., Triau, E., Vanbinst, A. - M., Versijpt, J., Bjerke, M., and Engelborghs, S.,
“A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER).”,
J Alzheimers Dis, vol. 63, no. 4, pp. 1509-1522, 2018.
E. Niemantsverdriet, Ribbens, A., Bastin, C., Benoit, F., Bergmans, B., Bier, J. - C., Bladt, R., Claes, L., De Deyn, P. Paul, Deryck, O., Hanseeuw, B., Ivanoiu, A., Lemper, J. - C., Mormont, E., Picard, G., Salmon, E., Segers, K., Sieben, A., Smeets, D., Struyfs, H., Thiery, E., Tournoy, J., Triau, E., Vanbinst, A. - M., Versijpt, J., Bjerke, M., and Engelborghs, S.,
“A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER).”,
J Alzheimers Dis, vol. 63, no. 4, pp. 1509-1522, 2018.
Y. Yan, Wu, X., Wang, X., Geng, Z., Wang, L., Xiao, G., Wu, Y., Zhou, S., Liao, R., Wei, L., Tian, Y., and Wang, K.,
“The Retinal Vessel Density Can Reflect Cognitive Function in Patients with Alzheimer's Disease: Evidence from Optical Coherence Tomography Angiography.”,
J Alzheimers Dis, vol. 79, no. 3, pp. 1307-1316, 2021.
C. Marr, McDowell, B., Holmes, C., Edwards, C. J., Cardwell, C., McHenry, M., Meenagh, G., Teeling, J. L., and McGuinness, B.,
“The RESIST Study: Examining Cognitive Change in Rheumatoid Arthritis Patients with Mild Cognitive Impairment Being Treated with a TNF-Inhibitor Compared to a Conventional Synthetic Disease-Modifying Anti-Rheumatic Drug.”,
J Alzheimers Dis, vol. 99, no. 1, pp. 161-175, 2024.
J. Li, Long, X., Huang, H., Tang, J., Zhu, C., Hu, S., Wu, J., Li, J., Lin, Z., and Xiong, N.,
“Resilience of Alzheimer's Disease to COVID-19.”,
J Alzheimers Dis, vol. 77, no. 1, pp. 67-73, 2020.
P. S. Aisen, Andrieu, S., Sampaio, C., Carrillo, M., Khachaturian, Z. S., Dubois, B., Feldman, H. H., Petersen, R. C., Siemers, E., Doody, R. S., Hendrix, S. B., Grundman, M., Schneider, L. S., Schindler, R. J., Salmon, E., Potter, W. Z., Thomas, R. G., Salmon, D., Donohue, M., Bednar, M. M., Touchon, J., and Vellas, B.,
“Report of the task force on designing clinical trials in early (predementia) AD.”,
Neurology, vol. 76, no. 3, pp. 280-6, 2011.
P. S. Aisen, Andrieu, S., Sampaio, C., Carrillo, M., Khachaturian, Z. S., Dubois, B., Feldman, H. H., Petersen, R. C., Siemers, E., Doody, R. S., Hendrix, S. B., Grundman, M., Schneider, L. S., Schindler, R. J., Salmon, E., Potter, W. Z., Thomas, R. G., Salmon, D., Donohue, M., Bednar, M. M., Touchon, J., and Vellas, B.,
“Report of the task force on designing clinical trials in early (predementia) AD.”,
Neurology, vol. 76, no. 3, pp. 280-6, 2011.
N. Terry, Masliah, A., Overk, C., and Masliah, E.,
“Remembering Robert D. Terry at a Time of Change in the World of Alzheimer's Disease.”,
J Alzheimers Dis, vol. 70, no. 3, pp. 621-628, 2019.
N. Rai, Kumar, R., Desai, G. Rajesh, Venugopalan, G., Shekhar, S., Chatterjee, P., Tripathi, M., Upadhyay, A. Datt, Dwivedi, S., Dey, A. B., and Dey, S.,
“Relative Alterations in Blood-Based Levels of Sestrin in Alzheimer's Disease and Mild Cognitive Impairment Patients.”,
J Alzheimers Dis, vol. 54, no. 3, pp. 1147-1155, 2016.